The discovery of nanobodies by Raymond Hamers in the 1980s and the further development of the technology by Serge Muyldermans and Jan Steyaert fundamentally changed approaches in different areas of medicine. Nanobodies are very useful in the diagnosis and treatment of serious and life-threatening diseases.
Nanobodies are single domain antibodies derived from llama heavy-chain only antibodies (HCAbs)
As nanobodies were born at the University of Brussels, the VIB-VUB Center for Structural Biology is very honored to organize the second edition of the Nanobody conference. This meeting series was launched in September 2019 at the University of Bonn by Florian Schmidt and Paul-Albert König.
During the 2day conference on 8-9 September 2021, leaders in the field will present their latest findings in sessions focused on:
Innovative research tools
Nanobodies in diagnostics, imaging and microscopy
Nanobodies in target validation
Nanobodies as therapeutic molecules
Nanobodies as anti-infectious agents
On Friday 10 September, a satellite event ‘Nanobodies in structural biology’ will be hold.